Newave Pharmaceutical
CA - PleasantonPharmaceutical
Focus: Newave Pharmaceutical is an early-stage oncology-focused biotech founded in 2021, developing small molecule therapies targeting hematologic malignancies. The company is pre-revenue with a pipeline of 6 clinical programs across Phase 1, 2, and 3.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Newave Pharmaceutical
AI assessmentNot HiringNo open roles listed right now. Follow Newave Pharmaceutical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
LP-108
AML/MDSClinical Trials (1)
NCT04139434Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML
Phase 1Help build intelligence for Newave Pharmaceutical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.